Podcast Index
Browse podcasts by category, open recent episodes, and download audio to listen offline.
Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders
David Brühlmann - CMC Development Leader, Bioprocess Expert, Business Strategist
Farming Today
BBC Radio 4
Das Universum
Florian Freistetter, Ruth Grützbauch, Evi Pech
StarTalk Radio
Neil deGrasse Tyson
Bacteriófagos
Carmela García Doval
Pharma and BioTech Daily
Pharma and BioTech News
Digimasters Shorts
Adam Nagus, Carly Wilson
Ogami Station
RatedPower
Engines of Our Ingenuity
Houston Public Media
Chronicles of Aetherius
Robert Bower
Qiological Podcast
Michael Max
Il Risveglio del Sogno Podcast
Michele Battuello
WeedSmart Podcast
WeedSmart
The Incubator
Ben Courchia & Daphna Yasova Barbeau
OYSTER-ology
Kevin Cox
Urban Radar
Tom Goodfellow and Beth Perry
Bigfoot Society
Jeremiah Byron
Transmission
Ysabelle Swan
Relatos 3roticos En Español ORIGINAL
Eric
PBS Space Time
PBS
Adventure Sports Podcast
Curt Linville
Nature's Archive
Michael Hawk
The Jordan Harbinger Show
Jordan Harbinger
The Constant: A History of Getting Things Wrong
Mark Chrisler
BJGP Interviews
The British Journal of General Practice
Earthlings 2.0 Podcast
Lisa Ann Pinkerton
Human Factors Minute
Human Factors Cast
Three Do Who
Mike Beagen, Eric Stevens, James Hadwen-Bennett
Today's Creation Moment
Creation Moments
Flooba
A Sensory Sound Space for Neurodivergent Minds
सद्गुरु हिन्दी
Sadhguru Hindi
Space News and Weather Today – Auroras, Rocket Launches & Night Sky Viewing
Caloroga Labs Space News and Weather
New Books in Anthropology
New Books Network
The Archaeology Podcast Network Feed
The Archaeology Podcast Network
The Chemical Show: Where Leaders Talk Business
Victoria Meyer
Modern Math Teacher- Teaching Strategies for High School and Middle School Math Teachers
Kristen Moore- High School Algebra Teacher + AI Educator + PBL Coach
Long Covid Doctor
Dr Tim Robinson
Science
David Brühlmann - CMC Development Leader, Bioprocess Expert, Business Strategist
What if the simple act of opening an incubator could undermine the consistency of your cell therapy manufacturing process? Unlike traditional biologics, the moment cells leave their incubator, subtle shifts in temperatur...
Digital transformation in biotech is no longer just about adopting new tools, it's about building a foundation where automation, data standardization, and AI integration actually lead to real value and long-term success....
Despite cutting-edge equipment and brilliant minds, biotech labs often find half their data trapped in difficult-to-access spreadsheets or isolated in silos, making true digital transformation a major, industry-wide hurd...
Host David Brühlmann returns for a focused solo episode to provide an honest, data-driven perspective on the evolving landscape of host selection for biologics manufacturing. Building on part one, David reviews five alte...
In this solo episode, David Brühlmann explores the evolving landscape of biologic manufacturing platforms beyond CHO (Chinese hamster ovary) cells. Drawing from previous interviews with platform pioneers and rigorous dat...
Funding novel therapeutics isn’t just “harder than ever”—the rules have changed entirely. The wild rush of capital into early-stage biotech during 2020–2021 gave way to a drought, making investor priorities sharper and s...
Strong science alone won’t get your biotech startup funded—investors are sizing up much more than just your molecule.Michael Rome, who leads therapeutics investing at Foresite Capital, brings a rare dual lens as both sci...
What happens between scientific discovery and clinical trials? For too many drug candidates, the answer is “failure”—not because the idea lacked merit, but because the critical handoff between discovery and IND-enabling ...
The gap between a “drug” and a true “product” is where many therapies fail.Milan Tomic, biotech veteran, GMP manufacturing expert, and founder of Albrem, has spent 30 years turning promising science into scalable, execut...
The "data lake" that was supposed to unify bioprocessing intelligence has, in most companies, become something else entirely: a data swamp, where information goes in and insight rarely comes back out. For anyone trying t...
When AI can draft a literature review in minutes, the question bioprocess educators can no longer avoid is this: what does a student actually need to learn?Steffen Kreye has a clear answer. As Professor of Industrial Bio...
Can aging be fundamentally slowed or even reversed—not by science fiction, but by harnessing the unassuming power of super-early stem cells?In Part 1, Yuta Lee, Founder and CEO of Accelerated Bio, walked through the biol...
What if the key to scalable, off-the-shelf cell therapy was hiding in tissue that surgeons discard every day?Yuta Lee, Founder and CEO of Accelerated Bio, has spent two decades building a cell therapy platform on exactly...
Are you still using one-factor-at-a-time experiments for biosimilar development, losing months, missing interactions, and risking costly dead-ends?In this episode, David Brühlmann, host of the Smart Biotech Scientist Pod...
Are you stuck screening endless compounds in biosimilar development and still not hitting your quality targets? Efficient compound screening is one of the toughest bottlenecks in biopharma, with outdated methods slowing ...
When every batch belongs to a single patient, a single centralized facility cannot serve the world. In Part 2, Chantale Bernatchez moves from process development into the broader consequences of that reality: the manufac...
The most underappreciated parameter in cell therapy process development is not your bioreactor, your media, or your activation protocol. It is the patient. Chantale Bernatchez has spent 20 years learning that lesson the ...
Getting an NDA signed shouldn't take weeks. If your CRO needs more than 48 hours to start the paperwork, your project timeline is already moving in the wrong direction.Ron Najafi knows what rigorous analytical work actua...
When drug safety fails, patients and entire markets pay the price. Understanding your CMC isn't just compliance — it's the line between therapeutic promise and product recall.Ron Najafi has lived that reality firsthand. ...
Shear sensitivity is the silent challenge behind many advanced biomanufacturing modalities. Orbital-shaken bioreactors—often underestimated—may be a key enabler your CMC development is missing.Tibor Anderlei, CSO at Kühn...
Fill in the form below. Make sure to select both Country and Genres.
Send us a message below. We will get back to you within 24 hours.